Changes in medication adherence and unused drugs after switching from daily dipeptidyl peptidase-4 inhibitors to once-weekly trelagliptin in patients with type 2 diabetes-Reference-Cited by-同舟云学术

Changes in medication adherence and unused drugs after switching from daily dipeptidyl peptidase-4 inhibitors to once-weekly trelagliptin in patients with type 2 diabetes

Published:2019-07 Issue: Volume:153 Page:41-48
ISSN:0168-8227
Container-title:Diabetes Research and Clinical Practice
language:en
Short-container-title:Diabetes Research and Clinical Practice

Author:

Ito Hiroyuki,Ando Shigenori,Tsugami Emiko,Araki Rie,Kusano Eiji,Matsumoto Suzuko,Uemura Kosuke,Nishio Shinya,Antoku Shinichi,Yamasaki Tomoko,Mori Toshiko,Togane Michiko

Publisher

Elsevier BV

Subject

Endocrinology,General Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference35 articles.

1. Primary medication non-adherence: analysis of 195,930 electronic prescriptions;Fischer;J Gen Intern Med,2010

2. Impact of dosage frequency on patient compliance;Paes;Diab Care,1997

3. Dosing frequency and medication adherence in chronic disease;Coleman;J Manag Care Pharm,2012

4. The current status and background factors of unused drugs in patients with type 2 diabetes: a cross-sectional study using a questionnaire survey;Ando;J Jpn Diab Soc,2018

5. Determinants of adherence to diabetes medications: findings from a large pharmacy claims database;Kirkman;Diab Care,2015

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Overcoming Low Adherence to Chronic Medications by Improving their Effectiveness using a Personalized Second-generation Digital System;Current Pharmaceutical Biotechnology;2024-12

2. Glycemic control of once-weekly and other administration frequencies for DPP-4 inhibitor in patients with type 2 diabetes: a real-world retrospective cohort study;Diabetology International;2024-04-13

3. Comparison of medication persistence and adherence in type 2 diabetes using a once-weekly regimen of DPP-4 inhibitor compared with once-daily and twice-daily regimens: a retrospective cohort study of Japanese health insurance claims data;Diabetology International;2024-04-03

4. Development of Long-Acting Dipeptidyl Peptidase-4 Inhibitors: Structural Evolution and Long-Acting Determinants;Journal of Medicinal Chemistry;2023-08-30

5. Safety and efficacy of once weekly dipeptidyl-peptidase-4 inhibitor trelagliptin in type-2 diabetes: A meta-analysis;Diabetes & Metabolic Syndrome: Clinical Research & Reviews;2022-04